These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38135644)

  • 1. Safety and effectiveness of remdesivir for the treatment of COVID-19 patients with end-stage renal disease: A retrospective cohort study.
    Huang YB; Ng CJ; Chiu CH; Chaou CH; Gao SY; Chen SY
    J Microbiol Immunol Infect; 2024 Feb; 57(1):76-84. PubMed ID: 38135644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: Severe SARS-CoV-2 Infection Treated with Remdesivir in a Patient with ESRD.
    Patel RH; Pella PM; Haider N; Blanco R
    Infect Disord Drug Targets; 2022; 22(3):e011221198456. PubMed ID: 34852751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Propensity Score-Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease.
    Seethapathy R; Zhao S; Long JD; Strohbehn IA; Sise ME
    Kidney360; 2022 Feb; 3(2):269-278. PubMed ID: 35373125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
    Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
    J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study.
    Gressens SB; Esnault V; De Castro N; Sellier P; Sene D; Chantelot L; Hervier B; Delaugerre C; Chevret S; Molina JM;
    PLoS One; 2022; 17(2):e0262564. PubMed ID: 35176057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical safety of remdesivir therapy in COVID-19 patients with renal insufficiency.
    Park S; Kim AR; Lee J; Kang SW; Sung H; Kim MN; Chang E; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Song EH; Chong YP
    J Infect Chemother; 2024 Apr; 30(4):366-370. PubMed ID: 37935348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir for the treatment of COVID-19.
    Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19.
    Garibaldi BT; Wang K; Robinson ML; Zeger SL; Bandeen-Roche K; Wang MC; Alexander GC; Gupta A; Bollinger R; Xu Y
    JAMA Netw Open; 2021 Mar; 4(3):e213071. PubMed ID: 33760094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Improvement, Outcomes, Antiviral Activity, and Costs Associated With Early Treatment With Remdesivir for Patients With Coronavirus Disease 2019 (COVID-19).
    Wong CKH; Lau KTK; Au ICH; Xiong X; Lau EHY; Cowling BJ
    Clin Infect Dis; 2022 Apr; 74(8):1450-1458. PubMed ID: 34265054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study.
    Joo EJ; Ko JH; Kim SE; Kang SJ; Baek JH; Heo EY; Shi HJ; Eom JS; Choe PG; Bae S; Ra SH; Kim DY; Kim BN; Kang YM; Kim JY; Chung JW; Chang HH; Bae S; Cheon S; Park Y; Choi H; Lee E; Lee BY; Park JW; Sohn Y; Heo JY; Kim SH; Peck KR
    J Korean Med Sci; 2021 Mar; 36(11):e83. PubMed ID: 33754512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Valid Warning or Clinical Lore: an Evaluation of Safety Outcomes of Remdesivir in Patients with Impaired Renal Function from a Multicenter Matched Cohort.
    Ackley TW; McManus D; Topal JE; Cicali B; Shah S
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33229428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study.
    Hussain Alsayed HA; Saheb Sharif-Askari F; Saheb Sharif-Askari N; Hussain AAS; Hamid Q; Halwani R
    PLoS One; 2021; 16(10):e0258643. PubMed ID: 34699552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
    Spinner CD; Gottlieb RL; Criner GJ; Arribas López JR; Cattelan AM; Soriano Viladomiu A; Ogbuagu O; Malhotra P; Mullane KM; Castagna A; Chai LYA; Roestenberg M; Tsang OTY; Bernasconi E; Le Turnier P; Chang SC; SenGupta D; Hyland RH; Osinusi AO; Cao H; Blair C; Wang H; Gaggar A; Brainard DM; McPhail MJ; Bhagani S; Ahn MY; Sanyal AJ; Huhn G; Marty FM;
    JAMA; 2020 Sep; 324(11):1048-1057. PubMed ID: 32821939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remdesivir treatment in hospitalized patients affected by COVID-19 pneumonia: A case-control study.
    Boglione L; Dodaro V; Meli G; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Borrè S
    J Med Virol; 2022 Aug; 94(8):3653-3660. PubMed ID: 35411627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis.
    Sörgel F; Malin JJ; Hagmann H; Kinzig M; Bilal M; Eichenauer DA; Scherf-Clavel O; Simonis A; El Tabei L; Fuhr U; Rybniker J
    J Antimicrob Chemother; 2021 Feb; 76(3):825-827. PubMed ID: 33251541
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study.
    Mozaffari E; Chandak A; Gottlieb RL; Chima-Melton C; Kalil AC; Sarda V; Der-Torossian C; Oppelt T; Berry M; Amin AN
    J Comp Eff Res; 2024 Apr; 13(4):e230131. PubMed ID: 38420658
    [No Abstract]   [Full Text] [Related]  

  • 18. Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study.
    Biancalana E; Chiriacò M; Sciarrone P; Mengozzi A; Mechelli S; Taddei S; Solini A
    Clin Interv Aging; 2021; 16():1037-1046. PubMed ID: 34113086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey.
    Oksuz E; Malhan S; Gonen MS; Kutlubay Z; Keskindemirci Y; Jarrett J; Sahin T; Ozcagli G; Bilgic A; Bibilik MO; Tabak F
    Adv Ther; 2021 Sep; 38(9):4935-4948. PubMed ID: 34379304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Remdesivir for Patients 80 Years of Age or Older with Coronavirus Disease 2019 (COVID-19).
    Kanai O; Fujita K; Nanba K; Esaka N; Hata H; Seta K; Yasoda A; Odagaki T; Mio T
    Drugs Aging; 2021 Dec; 38(12):1067-1074. PubMed ID: 34859387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.